Acino ? Delivering Health
Acino ? Delivering Health Acino ? Delivering Health
What changes after the Mepha/Cephalon Acquisition? 18
The acquisition includes: The marketing authorizations for a portfolio of 28 products from Mepha and the former Cephalon for Middle East, Africa, Latin America & Asia Direct presence in 60 countries The Mepha/Cephalon product and umbrellar brands for these regions All intellectual property for these products/brands All existing contracts with suppliers and distributors The inventory for these markets Part of the Mepha R&D pipeline The manufacturing, R&D and corporate office facilities in Aesch Manufacturing contracts with TEVA for former intercompany sales 19
- Page 1 and 2: Acino - Delivering Health Annual Re
- Page 3 and 4: 2011 operating performance EUR mill
- Page 5 and 6: Balance sheet EUR million 31.12.201
- Page 7 and 8: R&D and development pipeline Zurich
- Page 9 and 10: In-house technologies Complex, soli
- Page 11 and 12: In-house technologies Bio-degradabl
- Page 13 and 14: From 2013 onwards 2-3 projects per
- Page 15 and 16: “Old” Acino: highly dependent o
- Page 17: 3-pillar business model of Acino Ac
- Page 21 and 22: Acquired business perfectly fits Ac
- Page 23 and 24: The “new” Acino: broad customer
- Page 25 and 26: Geographic break-down of revenue Ma
- Page 27 and 28: Our past and future strengths Expan
- Page 29 and 30: Key Facts: Acino TODAY Fourth large
- Page 31: Acino - Delivering Health Thank you
What changes after the<br />
Mepha/Cephalon Acquisition?<br />
18
Change language